Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05520970

Recruitment Status : Terminated (Study early terminated based on the sponsor(manufacture)'s decision)

First Posted : August 30, 2022

Last Update Posted : June 22, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

International Vaccine Institute

Information provided by (Responsible Party):

Cellid Co., Ltd.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	November 8, 2022
Actual Study Completion Date :	November 8, 2022

To Top